40 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
) in the event of litigation or other dispute resolution, the Rights Agent may engage and consult with regulatory experts, drug development experts
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
of the acquisition; significant Transaction costs and/or unknown or inestimable liabilities; the risk of shareholder litigation in connection with the proposed
6-K
EX-99.1
8kus6gm9 dhan7
25 Feb 22
Current report (foreign)
4:05pm
424B3
63hw zya7f9mvmbgj
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
edbr82lfmqykumigxtrb
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
425
7fflv3 no
15 Jun 21
Business combination disclosure
4:28pm
F-4
13geijwid8 fv2j3v5i
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
mh1kxfpd nkndmx64
2 Jun 21
Prospectus supplement
10:10am
424B3
a4z8op
2 Jun 21
Prospectus supplement
10:09am
425
v75 nh0ucowb
5 May 21
Business combination disclosure
5:27pm
425
plm8a6dmr2m s6kb
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.1
6wc7vq5qkhw7a0i97lr
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
byc0ulxwuo5y
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
1w2mc2pwzp 7fu
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
0dajkdb5hoqbiome13
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
sgvwct x8adjmukd2q
30 Apr 21
Annual report (foreign)
12:53pm
424B4
zlrm4p e4
14 Jan 21
Prospectus supplement with pricing info
9:30am